DBC1 anticorps
-
- Antigène Voir toutes DBC1 (BRINP1) Anticorps
- DBC1 (BRINP1) (Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1))
-
Reactivité
- Humain, Souris
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp DBC1 est non-conjugé
-
Application
- Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Immunogène
- Recombinant Protein
-
-
- Indications d'application
- IP: 1:500. WB: 1:500. ICC: 1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Stock
- 4 °C,-20 °C
-
- Antigène
- DBC1 (BRINP1) (Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1))
- Autre désignation
- DBC1 (BRINP1 Produits)
- Synonymes
- anticorps Dbc1, anticorps Dbccr1, anticorps BRINP, anticorps Fam5a, anticorps BMP/retinoic acid inducible neural specific 1, anticorps bone morphogenic protein/retinoic acid inducible neural specific 1, anticorps Brinp1, anticorps BRINP1
- Sujet
- Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions. Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis. Inhibits SUV39H1 methyltransferase activity. As part of a histone H3- specific methyltransferase complex may mediate ligand-dependent transcriptional activation by nuclear hormone receptors. Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress. Regulates the circadian expression of the core clock components NR1D1 and ARNTL/BMAL1. Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation.
- UniProt
- Q8N163
-